IGM Biosciences (IGMS) Price & Analysis

Compare

343 Followers

IGMS Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.92 - $22.50

Previous CloseN/A

Volume43.44K

Average Volume (3M)540.92K

Market Cap

$80.57M

Enterprise Value-$35.14M

Total Cash (Recent Filing)$104.31M

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)―

Beta1.81

Next Earnings

Aug 11, 2025

EPS Estimate

-0.23

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.38

Shares Outstanding36,593,204

10 Day Avg. Volume282,060

30 Day Avg. Volume540,919

Financial Highlights & Ratios

PEG Ratio0.06

Price to Book (P/B)7.68

Price to Sales (P/S)138.02

P/FCF Ratio-2.33

Enterprise Value/Market Cap-0.44

Enterprise Value/Revenue-0.24

Enterprise Value/Gross Profit-0.25

Enterprise Value/Ebitda1.12

Forecast

1Y Price Target

$1.00

Price Target Upside-21.26% Downside

Rating ConsensusHold

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Business PriorityThe collaboration with SNY focused on the exclusive development of IgM agonist antibodies against inflammatory and autoimmune targets remains a top business priority and is making progress.

Strategic CollaborationThe ongoing collaboration with Sanofi on a different IGM molecule is still active and may generate potential future milestones or royalties.

Bears Say

Clinical Program DiscontinuationThe company discontinued all clinical development of its autoimmune franchise due to insufficient efficacy in meeting the required benchmarks.

Stock Price Target DowngradeReducing price target to $2 from $12 previously due to the removal of revenues for imvotamab and IGM-2644 from the model.

Workforce ReductionA significant reduction in workforce by 73% was implemented to preserve cash resources.

IGM Biosciences News

IGM Biosciences Merges with Concentra Biosciences

IGM Biosciences ( ($IGMS) ) has issued an update. On August 14, 2025, IGM Biosciences completed a merger...

9h ago

IGMS

IGMS Earnings this Week: How Will it Perform?

Igm Biosciences (IGMS) is scheduled to report 2nd quarter earnings on 08/11/2025. Regarding Q2 estimates, Wall Street analysts...

6d ago

IGMS

IGM Biosciences moved to No Rating at BofA

BofA moves to No Rating from Underperform on IGM Biosciences (IGMS) after the company announced an agreement to...

1M ago

IGMS

IGM Biosciences Announces Merger with Concentra Biosciences

IGM Biosciences ( ($IGMS) ) just unveiled an announcement. On July 1, 2025, IGM Biosciences announced a merger...

1M ago

IGMS

IGM Biosciences be acquired by Concentra for $1.247 in cash per share

IGM Biosciences (IGMS) announced that it has entered into a definitive merger agreement with Concentra Biosciences, whereby Concentra...

1M ago

IGMS

IGM Biosciences Faces Nasdaq Non-Compliance Notice

IGM Biosciences ( ($IGMS) ) has issued an update. On June 6, 2025, IGM Biosciences received a notice...

2M ago

IGMS

IGM Biosciences price target lowered to $1 from $2 at Truist

Truist lowered the firm’s price target on IGM Biosciences (IGMS) to $1 from $2 and keeps a Hold...

2M ago

IGMS

IGM Biosciences Reports Increased Net Loss Amid Strategic Focus

Igm Biosciences ( ($IGMS) ) has released its Q1 earnings. Here is a breakdown of the information Igm...

2M ago

IGMS

IGM Biosciences Terminates Headquarters Lease Agreement

IGM Biosciences ( ($IGMS) ) has issued an announcement. On May 23, 2025, IGM Biosciences, Inc. entered into...

3M ago

IGMS

IGM Biosciences Ends Genzyme Collaboration, Cuts Workforce

IGM Biosciences ( ($IGMS) ) just unveiled an update. On May 5, 2025, IGM Biosciences announced the termination...

3M ago

IGMS

IGM Biosciences downgraded to Underperform from Neutral at BofA

BofA downgraded IGM Biosciences (IGMS) to Underperform from Neutral with a price target of 75c, down from $2,...

4M ago

SNY

IGMS

IGMS Upcoming Earnings Report: What to Expect?

Igm Biosciences (IGMS) is scheduled to report 4th quarter earnings on 03/27/2025. Regarding Q4 estimates, Wall Street analysts...

5M ago

IGMS

IGM Biosciences Faces Uncertainty Amid Cash Preservation and Restructuring Efforts

Igm Biosciences (IGMS) has disclosed a new risk, in the Costs category. Igm Biosciences faces a potential risk...

5M ago

IGMS

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by...

7M ago

DTIL

IGMS

IGMS FAQ

What was IGM Biosciences Inc’s price range in the past 12 months?

IGM Biosciences Inc lowest stock price was $0.92 and its highest was $22.50 in the past 12 months.

What is IGM Biosciences Inc’s market cap?

IGM Biosciences Inc’s market cap is $80.57M.

When is IGM Biosciences Inc’s upcoming earnings report date?

IGM Biosciences Inc’s upcoming earnings report date is Aug 11, 2025 which is 4 days ago.

How were IGM Biosciences Inc’s earnings last quarter?

IGM Biosciences Inc released its earnings results on May 08, 2025. The company reported -$0.38 earnings per share for the quarter, missing the consensus estimate of -$0.347 by -$0.033.

Is IGM Biosciences Inc overvalued?

According to Wall Street analysts IGM Biosciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does IGM Biosciences Inc pay dividends?

IGM Biosciences Inc does not currently pay dividends.

What is IGM Biosciences Inc’s EPS estimate?

IGM Biosciences Inc’s EPS estimate is -0.23.

How many shares outstanding does IGM Biosciences Inc have?

IGM Biosciences Inc has 36,593,204 shares outstanding.

What happened to IGM Biosciences Inc’s price movement after its last earnings report?

IGM Biosciences Inc reported an EPS of -$0.38 in its last earnings report, missing expectations of -$0.347. Following the earnings report the stock price went up 1.575%.

Which hedge fund is a major shareholder of IGM Biosciences Inc?

Currently, no hedge funds are holding shares in IGMS

IGM Biosciences Stock Smart Score

Underperform

Fundamentals

Return on Equity

-47.82%

Trailing 12-Months

Asset Growth

-68.21%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

IGM Biosciences Inc

IGM Biosciences, Inc. is a biotechnology company focused on developing innovative therapies based on its proprietary IgM antibody platform. Founded in 2010, the company operates primarily in the biopharmaceutical sector, concentrating on the design and commercialization of novel therapeutics for the treatment of various cancers and autoimmune diseases. Its core products include IGM-2323, an investigational IgM antibody designed to target specific cancer cells, as well as other pipeline candidates aimed at addressing unmet medical needs.

IGM Biosciences (IGMS) Earnings & Revenues

Historic Earnings Reports

IGMS Stock 12 Month Forecast

Average Price Target

$1.00

▼(-21.26% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","17":"$17","4.25":"$4.25","8.5":"$8.5","12.75":"$12.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,4.25,8.5,12.75,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.31,1.2861538461538462,1.2623076923076924,1.2384615384615385,1.2146153846153847,1.1907692307692308,1.166923076923077,1.143076923076923,1.1192307692307693,1.0953846153846154,1.0715384615384616,1.0476923076923077,1.0238461538461539,{"y":1,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.31,1.2861538461538462,1.2623076923076924,1.2384615384615385,1.2146153846153847,1.1907692307692308,1.166923076923077,1.143076923076923,1.1192307692307693,1.0953846153846154,1.0715384615384616,1.0476923076923077,1.0238461538461539,{"y":1,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.31,1.2861538461538462,1.2623076923076924,1.2384615384615385,1.2146153846153847,1.1907692307692308,1.166923076923077,1.143076923076923,1.1192307692307693,1.0953846153846154,1.0715384615384616,1.0476923076923077,1.0238461538461539,{"y":1,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9.68,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.19,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.5,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.22,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.79,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.11,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.36,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.15,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.34,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.26,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.29,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.31,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >